Indoco Remedies Limited - Asset Resilience Ratio

Latest as of March 2026: 0.77%

Indoco Remedies Limited (INDOCO) has an Asset Resilience Ratio of 0.77% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Indoco Remedies Limited to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs199.10 Million

≈ $2.15 Million USD Cash + Short-term Investments

Total Assets

Rs25.93 Billion

≈ $280.45 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2004–2026)

This chart shows how Indoco Remedies Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see INDOCO current and non-current assets.

Liquid Assets Composition Over Time

This chart breaks down Indoco Remedies Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore INDOCO long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs199.10 Million	0.77%
Total Liquid Assets	Rs199.10 Million	0.77%

Asset Resilience Insights

Limited Liquidity: Indoco Remedies Limited maintains only 0.77% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Indoco Remedies Limited Industry Peers by Asset Resilience Ratio

Compare Indoco Remedies Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Dr. Reddy's Laboratories Limited F:RDDA	Drug Manufacturers - Specialty & Generic	11.36%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	48.48%
Apeloa Pharmaceutical Co Ltd SHE:000739	Drug Manufacturers - Specialty & Generic	0.00%
Zhejiang Huahai Pharmaceutical Co Ltd SHG:600521	Drug Manufacturers - Specialty & Generic	0.35%
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	Drug Manufacturers - Specialty & Generic	0.66%

Annual Asset Resilience Ratio for Indoco Remedies Limited (2004–2026)

The table below shows the annual Asset Resilience Ratio data for Indoco Remedies Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	0.77%	Rs199.10 Million ≈ $2.15 Million	Rs25.93 Billion ≈ $280.45 Million	+0.64pp
2025-03-31	0.13%	Rs32.20 Million ≈ $348.25K	Rs24.30 Billion ≈ $262.79 Million	-0.21pp
2024-03-31	0.34%	Rs72.44 Million ≈ $783.40K	Rs21.45 Billion ≈ $231.94 Million	+0.10pp
2023-03-31	0.24%	Rs39.95 Million ≈ $432.03K	Rs16.58 Billion ≈ $179.33 Million	-1.38pp
2022-03-31	1.63%	Rs241.50 Million ≈ $2.61 Million	Rs14.86 Billion ≈ $160.72 Million	+1.47pp
2021-03-31	0.16%	Rs21.00 Million ≈ $227.15K	Rs13.15 Billion ≈ $142.22 Million	-0.08pp
2020-03-31	0.24%	Rs29.97 Million ≈ $324.16K	Rs12.72 Billion ≈ $137.52 Million	-0.56pp
2019-03-31	0.79%	Rs99.77 Million ≈ $1.08 Million	Rs12.58 Billion ≈ $136.05 Million	+0.65pp
2018-03-31	0.14%	Rs17.49 Million ≈ $189.10K	Rs12.36 Billion ≈ $133.70 Million	-1.15pp
2017-03-31	1.29%	Rs154.38 Million ≈ $1.67 Million	Rs11.97 Billion ≈ $129.45 Million	-0.29pp
2016-03-31	1.58%	Rs152.08 Million ≈ $1.64 Million	Rs9.64 Billion ≈ $104.23 Million	-6.62pp
2013-03-31	8.20%	Rs565.32 Million ≈ $6.11 Million	Rs6.89 Billion ≈ $74.55 Million	-4.04pp
2011-03-31	12.24%	Rs691.28 Million ≈ $7.48 Million	Rs5.65 Billion ≈ $61.06 Million	+1.07pp
2010-03-31	11.17%	Rs535.20 Million ≈ $5.79 Million	Rs4.79 Billion ≈ $51.81 Million	+1.19pp
2009-03-31	9.99%	Rs415.14 Million ≈ $4.49 Million	Rs4.16 Billion ≈ $44.96 Million	+9.23pp
2008-03-31	0.75%	Rs28.27 Million ≈ $305.73K	Rs3.75 Billion ≈ $40.50 Million	-5.19pp
2007-03-31	5.95%	Rs206.42 Million ≈ $2.23 Million	Rs3.47 Billion ≈ $37.53 Million	+0.88pp
2006-03-31	5.06%	Rs157.33 Million ≈ $1.70 Million	Rs3.11 Billion ≈ $33.60 Million	-0.04pp
2005-03-31	5.10%	Rs145.39 Million ≈ $1.57 Million	Rs2.85 Billion ≈ $30.81 Million	-2.38pp
2004-03-31	7.48%	Rs112.67 Million ≈ $1.22 Million	Rs1.51 Billion ≈ $16.28 Million	--

pp = percentage points

About Indoco Remedies Limited

NSE:INDOCO India Drug Manufacturers - Specialty & Generic

Market Cap

$249.90 Million

Rs23.11 Billion INR

Market Cap Rank

#15809 Global

#806 in India

Share Price

Rs250.70

Change (1 day)

-4.50%

52-Week Range

Rs164.00 - Rs308.60

All Time High

Rs511.66